These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
605 related items for PubMed ID: 7694807
1. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas. Guo YJ, Ma J, Wong JH, Lin SC, Chang HC, Bigby M, Sy MS. Cell Immunol; 1993 Nov; 152(1):186-99. PubMed ID: 7694807 [Abstract] [Full Text] [Related]
2. Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. Denning SM, Le PT, Singer KH, Haynes BF. J Immunol; 1990 Jan 01; 144(1):7-15. PubMed ID: 1967267 [Abstract] [Full Text] [Related]
3. CD44 contributes to T cell activation. Huet S, Groux H, Caillou B, Valentin H, Prieur AM, Bernard A. J Immunol; 1989 Aug 01; 143(3):798-801. PubMed ID: 2568380 [Abstract] [Full Text] [Related]
6. Analysis of CD4 and CD2 receptor function. Goldman SJ, Bierer BE, Burakoff SJ. Princess Takamatsu Symp; 1988 Aug 01; 19():149-60. PubMed ID: 2908352 [Abstract] [Full Text] [Related]
7. Induction of negative signal through CD2 during antigen-specific T cell activation. Ohno H, Nakamura T, Yagita H, Okumura K, Taniguchi M, Saito T. J Immunol; 1991 Oct 01; 147(7):2100-6. PubMed ID: 1680913 [Abstract] [Full Text] [Related]
8. Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induces adenosine 3',5'-cyclic monophosphate production in T lymphocytes. Hahn WC, Rosenstein Y, Burakoff SJ, Bierer BE. J Immunol; 1991 Jul 01; 147(1):14-21. PubMed ID: 1711070 [Abstract] [Full Text] [Related]
9. Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule. Gerli R, Bertotto A, Crupi S, Arcangeli C, Marinelli I, Spinozzi F, Cernetti C, Angelella P, Rambotti P. J Immunol; 1989 Apr 15; 142(8):2583-9. PubMed ID: 2564856 [Abstract] [Full Text] [Related]
13. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants. Yang SY, Chouaib S, Dupont B. J Immunol; 1986 Aug 15; 137(4):1097-100. PubMed ID: 2426350 [Abstract] [Full Text] [Related]
14. Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules. Merćep M, Bluestone JA, Noguchi PD, Ashwell JD. J Immunol; 1988 Jan 01; 140(1):324-35. PubMed ID: 2891766 [Abstract] [Full Text] [Related]
15. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies. White J, Haskins KM, Marrack P, Kappler J. J Immunol; 1983 Mar 01; 130(3):1033-7. PubMed ID: 6185566 [Abstract] [Full Text] [Related]
16. CD44 antibody against In(Lu)-related p80, lymphocyte-homing receptor molecule inhibits the binding of human erythrocytes to T cells. Hale LP, Singer KH, Haynes BF. J Immunol; 1989 Dec 15; 143(12):3944-8. PubMed ID: 2480381 [Abstract] [Full Text] [Related]
17. Uncoupling IL-2 production from apoptosis and TNF production by changing the signal through the TCR. Glickstein L, Macphail S, Stutman O. J Immunol; 1996 Mar 15; 156(6):2062-7. PubMed ID: 8690893 [Abstract] [Full Text] [Related]